Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporin in psoriasis: pathophysiology and experimental data

N Mozzanica1, P D Pigatto, A F Finzi

  • 1Dermatology Institute, University of Milan, Italy.

Dermatology (Basel, Switzerland)
|January 1, 1993
PubMed
Summary

Cyclosporin effectively manages severe psoriasis by modulating the immune response. It reduces T cells and alters dendritic cell populations in psoriatic plaques, while also inhibiting neutrophil chemotaxis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Sudden death and toxic metals following ingestion of a button battery.

International journal of legal medicine·2017
Same author

Maxillofacial gunshot wounds and diagnostic tests for lead in the blood.

The British journal of oral & maxillofacial surgery·2016
Same author

Mercury Poisoning in Operational Settings among Gilders.

The international journal of occupational and environmental medicine·2016

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Psoriasis pathogenesis involves the immune system.
  • Cyclosporin is an effective immunosuppressant for severe psoriasis.

Purpose of the Study:

  • To review the role of cellular immunity in psoriasis.
  • To explore cyclosporin's mechanisms of action in psoriasis.
  • To analyze changes in lesional immune infiltrate and neutrophil chemotaxis during cyclosporin treatment.

Main Methods:

  • Immunohistological evaluation of psoriatic plaques.
  • Assessment of immune cell populations (CD4+ T cells, Langerhans cells, CD1+ dendritic cells).
  • In vivo and in vitro studies of neutrophil chemotaxis.

Main Results:

  • Psoriatic plaques showed a CD4+ T cell infiltrate.
  • Cyclosporin treatment decreased T cells and normalized Langerhans cells.
  • Cyclosporin reduced in vivo neutrophil chemotaxis by blocking monocyte-derived cytokines.

Conclusions:

  • Cellular immunity, particularly T cells, plays a key role in psoriasis.
  • Cyclosporin exerts therapeutic effects by modulating immune cell infiltrates and neutrophil function.
  • Cyclosporin's action involves inhibiting pro-inflammatory cytokine production by monocytes.

Related Experiment Videos